Company Overview

Company name: Khiron Life Sciences (TSX: KHRN)
Description: Khiron Life Sciences Corp is a vertically integrated medical company with core operations in LatAma, and operational activity in Europe and North America. Khiron is the cannabis company in Colombia and licensed for the cultivation, production, domestic distribution, and international export of both low and high THC medical cannabis products. The company has a presence in Mexico, Peru, Uruguay, Brazil, UK, Spain, and Germany, where it is positioned to begin sales of medical cannabis.
Year founded: 2012
Parent company:
Industry: Healthcare | Group: | Code:
Employees: 348
City: Toronto
State: Ontario
Country: Canada

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue/Not Profitable
Ownership: Publicly Held
Exchange: TSX
Ticker: KHRN
Revenue (USD Million): 5,95
Gross profit (USD Million): 2,54
Net income (USD Million) -22,21
Enterprise value: 26,62
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period: TTM 3Q2020
Financing Status:
Number of active investors:
Profile last updated: 28-dic-2020
Last known valuation:
Last known valuation date: